Dr. Dale Bredesen and KAATSU’s Barrett Johnson on Making Alzheimer’s Prevention Practical

In a new interview with Barrett Johnson, Director of Operations at KAATSU, and Dr. Dale Bredesen shared how prevention-first strategies are transforming Alzheimer’s care. Dr. Bredesen explained that participants in the PreCODE program who begin early — addressing factors such as insulin resistance, inflammation, and toxin exposure — have not progressed to dementia.

Dr. Bredesen praised KAATSU technology for its role in improving circulation, insulin sensitivity, and brain energetics without strain. “KAATSU gives people more metabolic support for the brain, more benefit from every workout,” he said. “It’s an important tool for maintaining cognitive health as we age.”

He also encouraged early screening through Apollo’s BrainScan blood test and free Cognoscopy self-assessment at myCQtest.com, adding, “When treated early and comprehensively, cognitive decline can be prevented, or even reversed.”

Watch here: